Literature DB >> 29427262

Factor structure and clinical correlates of the 61-item Wender Utah Rating Scale (WURS).

Matthew Calamia1, Benjamin D Hill2, Mandi W Musso3, Russell D Pella4, Wm Drew Gouvier5.   

Abstract

The objective of this study was to assess the factor structure and clinical correlates of a 61-item version of the Wender Utah Rating Scale (WURS), a self-report retrospective measure of childhood problems, experiences, and behavior used in ADHD assessment. Given the currently mostly widely used form of the WURS was derived via a criterion-keyed approach, the study aimed to use latent variable modeling of the 61-item WURS to potentially identify more and more homogeneous set of items reflecting current conceptualizations of ADHD symptoms. Exploratory structural equation modeling was used to generate factor scores which were then correlated with neuropsychological measures of intelligence and executive attention as well as a broad measure of personality and emotional functioning. Support for a modified five-factor model was found: ADHD, disruptive mood and behavior, negative affectivity, social confidence, and academic problems. The ADHD factor differed somewhat from the traditional 25-item WURS short form largely through weaker associations with several measures of personality and psychopathology. This study identified a factor more aligned with DSM-5 conceptualization of ADHD as well as measures of other types of childhood characteristics and symptoms which may prove useful for both research and clinical practice.

Entities:  

Keywords:  ADHD; Neuropsychological assessment; PAI; Psychopathology; WURS

Mesh:

Year:  2018        PMID: 29427262     DOI: 10.1007/s12402-018-0251-3

Source DB:  PubMed          Journal:  Atten Defic Hyperact Disord        ISSN: 1866-6116


  1 in total

1.  Association of Wender Utah Rating Scale (WURS)-61 items with clinical psychiatric diagnosis in adulthood.

Authors:  Cliodhna Hanley; Faisal Saleem; Ignazio Graffeo; Geraldine McCarthy; Blánaid Gavin; Fiona McNicholas; Dimitrios Adamis
Journal:  Ir J Med Sci       Date:  2021-03-04       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.